Coronavirus Drug Report, Though Inconclusive, Sends Gilead Higher

  • 📰 WSJ
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 63%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Some analysts said not much could be learned from partial results at one hospital, and from a set of patients whose progress wasn’t compared with a control group

An encouraging news report about an experimental drug being developed by Gilead Sciences Inc. for Covid-19 led shares of the drugmaker to jump nearly 8% in trading Friday and helped to spur gains in the total market.

A doctor in Chicago told colleagues that Gilead’s drug remdesivir appeared to help many patients enrolled in a clinical trial site at the University of Chicago Medicine hospital, according to a news report in online health publication STAT, which cited a video of the remarks. The doctor said that the hospital...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

SecAFOfficial WaldorfNYC

Who volunteers for the control group?

At least you can learn that nobody DIES from the drug.

What's impt is they had started a trial for the efficacy of the drug and new sampling designs for patient participants can be done for wider trials and more conclusive comparative analysis.

Well any news is good news, at the worst it atleast shows efficacy in some people; Heard from other MD’s in other states too telling it seems to work; let’s hope for the best and end to this fear

It would be great if COVID19 related articles were made available to nonsubscriber.

1,000 beyond numbers or words

At least it is a start. Now a broader study can be done. Work quickly please.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Gilead stock surges more than 10% on report of promising coronavirus treatmentGilead Sciences Inc. undefined shares rallied in the extended session Thursday following a report that one of the company's drugs showed promising results in... I heard it was a promise of a promise. Trader_Aadil Interesting timing though. After market close and before Trumps supposed big press conference to unveil the return to 'normality' aka reopening America Ah ok, it's one of those miracle silver bullets again...
Source: MarketWatch - 🏆 3. / 97 Read more »

Dow rises over 500 points as investors pin hope on Gilead coronavirus treatment and U.S. reopeningStocks opened with strong gains Friday, putting equities on track to end a positive week on a strong note, after a treatment for the deadly COVID-19 pandemic... Everybody can go outside! See you all out there!
Source: MarketWatch - 🏆 3. / 97 Read more »